Clinical Trial

The Progressive Supranuclear Palsy Clinical Trial Platform

Name: The Progressive Supranuclear Palsy Clinical Trial Platform — clinical trial record (NCT07173803)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PTP

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-06

Trial Details

NCT Number	NCT07173803
Lead Sponsor	Adam Boxer Collaborators: National Institute on Aging (NIA), Alzheimer's Therapeutic Research Institute, University of Southern California, Massachusetts General Hospital, University of California, San Diego, Alzheimer's Clinical Trials Consortium
Conditions	Progressive Supranuclear Palsy(PSP)
Enrollment	440 participants
Start Date	2026-07-29
Primary Completion	2030-09-28 (estimated)
Study Completion	2030-09-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-12